TCL Archive Letter to the Editors: Burzynski Responds To FDA Release Of Annual Report Data May 22, 1998
TCL Archive Georgetown-Hackensack Consortium Plan Points to Rising Value of NCI Designation April 19, 2013
TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009